{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20250925",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "83533",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218881s000lbl.pdf",
              "date": "20250926",
              "type": "Label"
            },
            {
              "id": "83543",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218881Orig1s000ltr.pdf",
              "date": "20250926",
              "type": "Letter"
            },
            {
              "id": "83915",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/218881Orig1s000TOC.html",
              "date": "20251027",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA218881",
      "sponsor_name": "ELI LILLY AND CO",
      "openfda": {
        "application_number": [
          "NDA218881"
        ],
        "brand_name": [
          "INLURIYO"
        ],
        "generic_name": [
          "IMLUNESTRANT"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-1717"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "IMLUNESTRANT"
        ],
        "rxcui": [
          "2725917",
          "2725923"
        ],
        "spl_id": [
          "d4c7332d-4da7-4d70-8813-4cecd53fff2a"
        ],
        "spl_set_id": [
          "5bc172e4-e8a2-441a-be52-279a7f890196"
        ],
        "package_ndc": [
          "0002-1717-28",
          "0002-1717-56",
          "0002-1717-61"
        ],
        "nui": [
          "N0000175582",
          "N0000000145",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Estrogen Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Antagonists [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "9CXQ3PF69U"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "INLURIYO",
          "active_ingredients": [
            {
              "name": "IMLUNESTRANT TOSYLATE",
              "strength": "EQ 200MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}